This inventor holds 2 USPTO granted patents. Top assignee: Monsanto Company. Active years: 1989-1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989-1992
Title: George I Glover: Innovator in Serine Protease Inhibition
Introduction
George I Glover is a notable inventor based in Creve Coeur, MO (US). He has made significant contributions to the field of biochemistry, particularly in the development of serine protease inhibitors. With a total of 2 patents, Glover's work has implications for various medical applications.
Latest Patents
Glover's latest patents focus on novel peptides that exhibit inhibitory activity toward serine proteases. One of his inventions provides peptides comprising a generic inhibitory core with a functional site recognition sequence fused to the N-terminus. This design enhances selectivity and potency for target proteases. Additionally, he has developed synthetic polypeptides that demonstrate potent serine protease inhibition. These methods and compositions are useful for treating conditions caused by unwanted serine protease activity.
Career Highlights
Glover is associated with Monsanto Company, where he has been able to apply his innovative ideas in a practical setting. His work has contributed to advancements in the understanding and treatment of various conditions related to serine proteases.
Collaborations
Glover has collaborated with Charles A McWherter, further enhancing the research and development efforts in his field.
Conclusion
George I Glover's contributions to the field of serine protease inhibitors highlight his innovative spirit and dedication to advancing biochemistry. His patents reflect a commitment to improving medical treatments and understanding complex biological processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile